← back to search

Fiona Lalloo

University of Manchester · GB
Area of research
Genetics · Pathology and Forensic Medicine
Research interest
Research interests include BRCA gene mutations in cancer, Genetic factors in colorectal cancer, Genomic variations and chromosomal abnormalities, and Breast Cancer Treatment Studies.
h-index
36
citations
10,804
works
100
NIH funding
primary concept
Medicine
email

Recent publications

Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines, Sixth Edition
The Journal of Laryngology & Otology 2024cited by 47position: middledoi
Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database
EClinicalMedicine 2023cited by 103position: middledoi
Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome
European Journal of Human Genetics 2023cited by 50position: firstdoi
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium
Breast Cancer Research 2023cited by 13position: middledoi
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants
npj Breast Cancer 2023cited by 7position: middledoi
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers
Communications Biology 2022cited by 14position: middledoi
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants
Research Square 2022cited by 0position: middledoi
Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study
The Lancet Oncology 2021cited by 117position: middledoi
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study
The Lancet Oncology 2021cited by 92position: middledoi
Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report
European Journal of Cancer 2021cited by 21position: middledoi
No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in MLH1 and MSH2: A Prospective Lynch Syndrome Database Study
Journal of Clinical Medicine 2021cited by 19position: middledoi
Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report
Genetics in Medicine 2020cited by 41position: middledoi
Correction: Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
Genetics in Medicine 2020cited by 10position: middledoi
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
Genetics in Medicine 2019cited by 638position: middledoi
Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report
Hereditary Cancer in Clinical Practice 2019cited by 63position: middledoi
Cancer risk and survival in <i>path_MMR</i> carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database
Gut 2017cited by 564position: middledoi
Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report
Hereditary Cancer in Clinical Practice 2017cited by 62position: middledoi
Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database
Gut 2016cited by 167position: middledoi
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus
Breast Cancer Research 2016cited by 75position: middledoi
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database
Gut 2015cited by 544position: middledoi
Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers
PLoS ONE 2015cited by 39position: middledoi
DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
PLoS Genetics 2014cited by 130position: middledoi
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts
Gut 2013cited by 743position: middledoi
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers
Breast Cancer Research 2012cited by 96position: middledoi
Association of PHB 1630 C&gt;T and MTHFR 677 C&gt;T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study
British Journal of Cancer 2012cited by 37position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

No co-authors indexed yet.